Correction to:[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6)

Autor: van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C.T., Dekker, H., van Dongen, G. A.M.S., Vugts, D. J., Boellaard, R., van Herpen, C. M.L., de Vries, E. G.E., Oyen, W. J.G., Brouwers, A. H., Verheul, H. M.W., Hoekstra, O. S., der Houven van Oordt, C. W.Menke van

Publikováno v: van Helden, E J, Elias, S G, Gerritse, S L, van Es, S C, Boon, E, Huisman, M C, van Grieken, N C T, Dekker, H, van Dongen, G A M S, Vugts, D J, Boellaard, R, van Herpen, C M L, de Vries, E G E, Oyen, W J G, Brouwers, A H, Verheul, H M W, Hoekstra, O S & der Houven van Oordt, C W M V 2020, ' Correction to : [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6) ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 10, pp. 2481 . https://doi.org/10.1007/s00259-020-04908-6

The Electronic Supplementary Materials are missing in the original article. Kindly check the Electronic Supplementary Materials in this article. The Publisher regrets this error.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::0c0938e5110305b00cc0d60e8bed533c
https://research.vumc.nl/en/publications/0c4bd5ae-9627-44b4-9087-a375c3e76a80